Progress toward curing HIV infection with hematopoietic cell transplantation

Lawrence D Petz,1 John C Burnett,2 Haitang Li,3 Shirley Li,3 Richard Tonai,1 Milena Bakalinskaya,4 Elizabeth J Shpall,5 Sue Armitage,6 Joanne Kurtzberg,7 Donna M Regan,8 Pamela Clark,9 Sergio Querol,10 Jonathan A Gutman,11 Stephen R Spellman,12 Loren Gragert,13 John J Rossi2 1StemCyte International...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Petz LD, Burnett JC, Li HT, Li S, Tonai R, Bakalinskaya M, Shpall EJ, Armitage S, Kurtzberg J, Regan DM, Clark P, Querol S, Gutman JA, Spellman SR, Gragert L, Rossi JJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/5a466ee08fd143b7b458dc06677afa63
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5a466ee08fd143b7b458dc06677afa63
record_format dspace
spelling oai:doaj.org-article:5a466ee08fd143b7b458dc06677afa632021-12-02T00:34:56ZProgress toward curing HIV infection with hematopoietic cell transplantation1178-6957https://doaj.org/article/5a466ee08fd143b7b458dc06677afa632015-07-01T00:00:00Zhttp://www.dovepress.com/progress-toward-curing-hiv-infection-with-hematopoietic-cell-transplan-peer-reviewed-article-SCCAAhttps://doaj.org/toc/1178-6957Lawrence D Petz,1 John C Burnett,2 Haitang Li,3 Shirley Li,3 Richard Tonai,1 Milena Bakalinskaya,4 Elizabeth J Shpall,5 Sue Armitage,6 Joanne Kurtzberg,7 Donna M Regan,8 Pamela Clark,9 Sergio Querol,10 Jonathan A Gutman,11 Stephen R Spellman,12 Loren Gragert,13 John J Rossi2 1StemCyte International Cord Blood Center, Baldwin Park, CA, USA; 2Department of Molecular and Cellular Biology, Irell and Manella Graduate School of Biological Sciences, 3Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA; 4CCR5-Δ32/Δ32 Research Department, StemCyte International Cord Blood Center, Baldwin Park, CA, USA; 5Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 6MD Anderson Cord Blood Bank, Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 7Carolinas Cord Blood Bank, Duke University Medical Center, Durham, NC, USA; 8St Louis Cord Blood Bank, SSM Cardinal Glennon Children's Medical Center, St Louis, MO, USA; 9Enhance Quality Consulting Inc., Oviedo, FL, USA; 10Cell Therapy Service and Cord Blood Bank, Banc de Sang i Teixits, Barcelona, Spain; 11BMT/Hematologic Malignancies, University of Colorado, Aurora, CO, USA; 12Immunobiology and Observational Research, CIBMTR, Minneapolis, MN, USA; 13National Marrow Donor Program/Be The Match, Minneapolis, MN, USA Abstract: HIV-1 infection afflicts more than 35 million people worldwide, according to 2014 estimates from the World Health Organization. For those individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. Indeed, the only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation (HCT) from a graft that carried the HIV-resistant CCR5-Δ32/Δ32 mutation. Other attempts to establish a cure for HIV/AIDS using HCT in patients with HIV-1 and malignancy have yielded mixed results, as encouraging evidence for virus eradication in a few cases has been offset by poor clinical outcomes due to the underlying cancer or other complications. Such clinical strategies have relied on HIV-resistant hematopoietic stem and progenitor cells that harbor the natural CCR5-Δ32/Δ32 mutation or that have been genetically modified for HIV-resistance. Nevertheless, HCT with HIV-resistant cord blood remains a promising option, particularly with inventories of CCR5-Δ32/Δ32 units or with genetically modified, human leukocyte antigen-matched cord blood. Keywords: curing HIV infection, hematopoietic cell transplantation, genetic modification of stem cells, CCR5 mutation, CCR5-Δ32/Δ32 cord blood inventoryPetz LDBurnett JCLi HTLi STonai RBakalinskaya MShpall EJArmitage SKurtzberg JRegan DMClark PQuerol SGutman JASpellman SRGragert LRossi JJDove Medical PressarticleCytologyQH573-671ENStem Cells and Cloning: Advances and Applications, Vol 2015, Iss default, Pp 109-116 (2015)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Petz LD
Burnett JC
Li HT
Li S
Tonai R
Bakalinskaya M
Shpall EJ
Armitage S
Kurtzberg J
Regan DM
Clark P
Querol S
Gutman JA
Spellman SR
Gragert L
Rossi JJ
Progress toward curing HIV infection with hematopoietic cell transplantation
description Lawrence D Petz,1 John C Burnett,2 Haitang Li,3 Shirley Li,3 Richard Tonai,1 Milena Bakalinskaya,4 Elizabeth J Shpall,5 Sue Armitage,6 Joanne Kurtzberg,7 Donna M Regan,8 Pamela Clark,9 Sergio Querol,10 Jonathan A Gutman,11 Stephen R Spellman,12 Loren Gragert,13 John J Rossi2 1StemCyte International Cord Blood Center, Baldwin Park, CA, USA; 2Department of Molecular and Cellular Biology, Irell and Manella Graduate School of Biological Sciences, 3Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA; 4CCR5-Δ32/Δ32 Research Department, StemCyte International Cord Blood Center, Baldwin Park, CA, USA; 5Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 6MD Anderson Cord Blood Bank, Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 7Carolinas Cord Blood Bank, Duke University Medical Center, Durham, NC, USA; 8St Louis Cord Blood Bank, SSM Cardinal Glennon Children's Medical Center, St Louis, MO, USA; 9Enhance Quality Consulting Inc., Oviedo, FL, USA; 10Cell Therapy Service and Cord Blood Bank, Banc de Sang i Teixits, Barcelona, Spain; 11BMT/Hematologic Malignancies, University of Colorado, Aurora, CO, USA; 12Immunobiology and Observational Research, CIBMTR, Minneapolis, MN, USA; 13National Marrow Donor Program/Be The Match, Minneapolis, MN, USA Abstract: HIV-1 infection afflicts more than 35 million people worldwide, according to 2014 estimates from the World Health Organization. For those individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. Indeed, the only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation (HCT) from a graft that carried the HIV-resistant CCR5-Δ32/Δ32 mutation. Other attempts to establish a cure for HIV/AIDS using HCT in patients with HIV-1 and malignancy have yielded mixed results, as encouraging evidence for virus eradication in a few cases has been offset by poor clinical outcomes due to the underlying cancer or other complications. Such clinical strategies have relied on HIV-resistant hematopoietic stem and progenitor cells that harbor the natural CCR5-Δ32/Δ32 mutation or that have been genetically modified for HIV-resistance. Nevertheless, HCT with HIV-resistant cord blood remains a promising option, particularly with inventories of CCR5-Δ32/Δ32 units or with genetically modified, human leukocyte antigen-matched cord blood. Keywords: curing HIV infection, hematopoietic cell transplantation, genetic modification of stem cells, CCR5 mutation, CCR5-Δ32/Δ32 cord blood inventory
format article
author Petz LD
Burnett JC
Li HT
Li S
Tonai R
Bakalinskaya M
Shpall EJ
Armitage S
Kurtzberg J
Regan DM
Clark P
Querol S
Gutman JA
Spellman SR
Gragert L
Rossi JJ
author_facet Petz LD
Burnett JC
Li HT
Li S
Tonai R
Bakalinskaya M
Shpall EJ
Armitage S
Kurtzberg J
Regan DM
Clark P
Querol S
Gutman JA
Spellman SR
Gragert L
Rossi JJ
author_sort Petz LD
title Progress toward curing HIV infection with hematopoietic cell transplantation
title_short Progress toward curing HIV infection with hematopoietic cell transplantation
title_full Progress toward curing HIV infection with hematopoietic cell transplantation
title_fullStr Progress toward curing HIV infection with hematopoietic cell transplantation
title_full_unstemmed Progress toward curing HIV infection with hematopoietic cell transplantation
title_sort progress toward curing hiv infection with hematopoietic cell transplantation
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/5a466ee08fd143b7b458dc06677afa63
work_keys_str_mv AT petzld progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT burnettjc progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT liht progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT lis progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT tonair progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT bakalinskayam progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT shpallej progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT armitages progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT kurtzbergj progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT regandm progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT clarkp progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT querols progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT gutmanja progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT spellmansr progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT gragertl progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
AT rossijj progresstowardcuringhivinfectionwithhematopoieticcelltransplantation
_version_ 1718403620369596416